Dr. Moulay Mustapha Ennaji, Professor in Virology and Oncology at the University of Casablanca and Director of the Quality and Medical Biotechnologies Team at Laboratory of Virology Microbiology, Hassan II University Mohammedia of Casablanca, Morocco He is currently a Professor in Virology and Oncology at the University of Casablanca, and since 2010, he has been the Director of the Quality and Medical Biotechnologies Team at the Laboratory of Virology Microbiology, Quality, Biotechnologies. He received a MSc in 1986 and a PhD in virology in 1993 from Armand Frappier Institute, University of Quebec (Canada). He has published dozens of journals articles and is an editorial board member of the journal, Infectious Agents and Cancer. Throughout his career, Dr. Ennaji has been rewarded several awards. At present, he is the vice president of the three Moroccan societies of Biosafety, Cancer, and Microbiology.

Select Guide Rating

• Volume 2: Medical Applications of Viral Oncology Research1. Virus Cancer Biology2. Lytic and Lysogenic oncoviruses3. Diagnostic, prognostic viral biomarkers4. Viral Biomarkers of various human cancers5. Mechanism of virus actions6. Future of cancer therapy of oncoviruses8. Recent advances in oncoviruses prevention and curative treatments9. Vaccine strategies10. Antiviral activities of oncoviruses11. Modeling of oncoviruses knowledge12. Bioinformatics for oncoviral studies13. Cell signaling and oncoviruses

Dr. Moulay Mustapha Ennaji, Professor in Virology and Oncology at the University of Casablanca and Director of the Quality and Medical Biotechnologies Team at Laboratory of Virology Microbiology, Hassan II University Mohammedia of Casablanca, Morocco He is currently a Professor in Virology and Oncology at the University of Casablanca, and since 2010, he has been the Director of the Quality and Medical Biotechnologies Team at the Laboratory of Virology Microbiology, Quality, Biotechnologies. He received a MSc in 1986 and a PhD in virology in 1993 from Armand Frappier Institute, University of Quebec (Canada). He has published dozens of journals articles and is an editorial board member of the journal, Infectious Agents and Cancer. Throughout his career, Dr. Ennaji has been rewarded several awards. At present, he is the vice president of the three Moroccan societies of Biosafety, Cancer, and Microbiology.

Select Guide Rating

• Volume 2: Medical Applications of Viral Oncology Research1. Virus Cancer Biology2. Lytic and Lysogenic oncoviruses3. Diagnostic, prognostic viral biomarkers4. Viral Biomarkers of various human cancers5. Mechanism of virus actions6. Future of cancer therapy of oncoviruses8. Recent advances in oncoviruses prevention and curative treatments9. Vaccine strategies10. Antiviral activities of oncoviruses11. Modeling of oncoviruses knowledge12. Bioinformatics for oncoviral studies13. Cell signaling and oncoviruses

Dr. Moulay Mustapha Ennaji, Professor in Virology and Oncology at the University of Casablanca and Director of the Quality and Medical Biotechnologies Team at Laboratory of Virology Microbiology, Hassan II University Mohammedia of Casablanca, Morocco He is currently a Professor in Virology and Oncology at the University of Casablanca, and since 2010, he has been the Director of the Quality and Medical Biotechnologies Team at the Laboratory of Virology Microbiology, Quality, Biotechnologies. He received a MSc in 1986 and a PhD in virology in 1993 from Armand Frappier Institute, University of Quebec (Canada). He has published dozens of journals articles and is an editorial board member of the journal, Infectious Agents and Cancer. Throughout his career, Dr. Ennaji has been rewarded several awards. At present, he is the vice president of the three Moroccan societies of Biosafety, Cancer, and Microbiology.

Select Guide Rating

• Volume 2: Medical Applications of Viral Oncology Research1. Virus Cancer Biology2. Lytic and Lysogenic oncoviruses3. Diagnostic, prognostic viral biomarkers4. Viral Biomarkers of various human cancers5. Mechanism of virus actions6. Future of cancer therapy of oncoviruses8. Recent advances in oncoviruses prevention and curative treatments9. Vaccine strategies10. Antiviral activities of oncoviruses11. Modeling of oncoviruses knowledge12. Bioinformatics for oncoviral studies13. Cell signaling and oncoviruses